Abstract:Two novel diorganotin (IV) complexes, based on 4-nitro-N-phthaloyl-glycine (HL), namely {4-NO2C6H3(CO)2NCH2COO}2Sn(n-Bu)2 (1) and {4-NO2C6H3(CO)2NCH2COO}2SnMe2 (2), were synthesized and characterized by elemental analysis, FT-IR, 1H- and 13C-NMR spectroscopic techniques. In vitro antitumor activities of both complexes were evaluated by the 3-(4,5-dimethylthiazoly-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay against three human cancer cell lines: HepG-2 (human liver carcinoma), SGC-7901 (human gastric carcinoma) and LS174T (human colon carcinoma). Complex 1 exhibited strong antitumor activity with IC50 values of 1.51±0.41, 1.80±0.63, and 2.48±0.96μM, respectively; while complex 2 had no obvious effects on the three selected cancer cell lines at high concentrations up to 100μM. Complex 1-induced apoptosis was further confirmed by morphological observations and annexin V-FITC/PI staining flow cytometry analysis in HepG-2 cells. Cell cycle analysis revealed that complex 1 caused cell cycle arrest at G2/M phase. Molecular mechanism studies suggested that the apoptosis was mediated through the mitochondrial pathway with intracellular reactive oxygen species (ROS) promotion and mitochondrial membrane potential (MMP) disruption by finally activating effector caspase-3/9 to trigger cell apoptosis. Moreover, the interactions of both complexes with calf thymus DNA (CT-DNA) were investigated by using UV-Vis titration and fluorometric competition measurements. The DNA-binding constants Kb (intrinsic binding constant) and Ksv (quenching constant) had been obtained in the order: 1>2, consisted with the antitumor activity results. Taken together, complex 1 exhibited excellent antitumor activity suggesting that it may be a potential candidate for further chemical optimization and cancer therapy.

Synthesis, crystal structure and antitumor activity of trialkyltin (IV) 9,10-anthraquinone-2-carboxylate

Synthesis, Crystal Structure and Antitumor Ability of a Fluorescent Organotin Compound

Synthesis, Crystal Structure and in Vitro Antitumor Activity of a Novel Organotin(iv) Complex with 9-Hexyl-9h-carbazole-3-carboxylic Acid

Synthesis and Anti-Tumor Activities of Three Newly Designed Organotin(iv) Carboxylates Complexes

Design, synthesis and mechanistic studies of novel arylformylhydrazone butylphenyltin complexes as potential anticancer agents

Synthesis, Structure, and Anticancer Activity of Two Organotin Heterocyclic Carboxylates Complexes

Diorganotin (IV) Complexes with 4-Nitro-n-phthaloyl-glycine: Synthesis, Characterization, Antitumor Activity and DNA-binding Studies

Synthesis, Structure and Antitumour Activity of Diorganotin(IV) Complexes Containing Silicon of Salicylaldehyde Thiosemicarbazone

Syntheses, Structures and Antitumor Activities of Organotin 5-Methyl/amino-1H-tetrazolyl-1-acetates

Synthesis of 2-{1-[(4-Formamidophenyl)acetoxy]alkyl}-1,4-dihydroxy-9,10-anthraquinone and Evaluation of Its Antitumor Activity

Synthesis, Anticancer Activity, and Mechanistic Investigations of Aryl-Alkyl Diorganotin Arylformylhydrazone Complexes

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Synthesis, structures, and cytotoxicity insights of organotin(IV) complexes with thiazole-appended pincer ligand

Synthesis, structural elucidation and anticancer activity of diorganotin(IV) complexes derived from isonicotinoyl hydrazones

Synthesis, Structure and Antitumor Activity of Organotin 1,1'-Methylenebis(1h-pyrazole-4-carboxylates)

Organotin(IV) Carboxylate Complexes Containing Polyether Oxygen Chains with Two-Photon Absorption in the Near Infrared Region and Their Anticancer Activity

Organotin(IV) carboxylates of (E)-3-(2-nitrophenyl) propenoic acid: Synthesis, spectroscopic characterization, crystal structure and antitumor activity

Synthesis, Characterization and Antitumour Activity of Diorganotin (iv) Complexes Containing Silicon of 2-Mercaptobenzothiazole

Synthesis , crystal structure and biological activities of four novel tetranuclear di-organotin ( IV ) carboxylates q

Diorganotin (IV) amino acid complexes as potential anticancer agents. Synthesis, structural characterization, and in vitro assays

New Tin (IV) and Organotin (IV) Complexes with a Hybrid Thiosemicarbazone/Hydrazone Ligand: Synthesis, Crystal Structure, and Antiproliferative Activity